生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Tropicamide is an anticholinergic and a muscarinic receptor subtype M4-preferring antagonist. Tropicamide causes a more rapid return of near vision and a lesser stinging sensation relative to cyclopentolate. And Tropicamide requires a shorter duration to obtain maximum cycloplegia, and rarely induces systemic side effects[3]. Moreover, the mixture containing 0.75% tropicamide and 2.5% phenylephrine was effective in pupil dilatation. It provided rapid and successful pupil dilatation for ophthalmoscopy, more than the alternate application of 1% tropicamide and 10% phenylephrine[4]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02124486 | Idiopathic Intracranial Hypert... 展开 >>ension 收起 << | Not Applicable | Active, not recruiting | August 2, 2022 | United Kingdom ... 展开 >> University Hospital Birmingham (Queen Elizabeth Hospital) Birmingham, West Midlands, United Kingdom, B15 2TH 收起 << |
NCT00817063 | Eczema | Phase 3 | Completed | - | - |
NCT00227253 | - | Recruiting | December 2025 | United States, Texas ... 展开 >> University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Jannine D Cody, Ph.D. 210-567-9220 cody@uthscsa.edu Contact: Daniel E Hale, M.D. 210-567-5284 hale@uthscsa.edu Principal Investigator: Jannine D. Cody, Ph.D. Sub-Investigator: Peter T. Fox, M.D. Principal Investigator: Daniel E. Hale, M.D. Sub-Investigator: Brian P Perry, M.D. 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.52mL 0.70mL 0.35mL |
17.58mL 3.52mL 1.76mL |
35.17mL 7.03mL 3.52mL |
参考文献 |
---|